- Home
- RVMD vs JBHT Comparison
RVMD vs JBHT Comparison
Compare RVMD & JBHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | JBHT |
|---|---|---|
| Founded | 2014 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 26.7B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RVMD | JBHT |
|---|---|---|
| Price | $208.19 | $273.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 20 |
| Target Price | $140.84 | ★ $220.80 |
| AVG Volume (30 Days) | ★ 1.6M | 813.4K |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ 10.07 |
| EPS | N/A | ★ 3.39 |
| Revenue | N/A | ★ $7,189,568,000.00 |
| Revenue This Year | N/A | $5.76 |
| Revenue Next Year | $533.02 | $6.62 |
| P/E Ratio | ★ N/A | $80.96 |
| Revenue Growth | N/A | ★ 9.67 |
| 52 Week Low | $35.62 | $130.13 |
| 52 Week High | $220.34 | $299.76 |
Technical Indicators
Market Signals| Indicator | RVMD | JBHT |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 47.61 |
| Support Level | $177.04 | $265.05 |
| Resistance Level | N/A | $296.09 |
| Average True Range (ATR) | 7.36 | 7.66 |
| MACD | 0.46 | 0.24 |
| Stochastic Oscillator | 71.41 | 46.19 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).